2026 RESULT OF ANNUAL GENERAL MEETING

AI SummaryClose X

ImmuPharma PLC announced the results of its Annual General Meeting, confirming that all six resolutions, including the re-appointment of Ketan Patel as director and Crowe UK LLP as auditor, were passed by shareholders with strong support, ranging from 93% to 99% of votes cast. The company also received shareholder approval for directors to allot shares and adopt new Articles of Association, with 152,641,450 shares (94%) voting in favour of the first share allotment resolution and 151,322,867 shares (93%) for the second special resolution. The total number of issued ordinary shares eligible to vote was 623,911,379.

Disclaimer*

Companies

Immupharma (IMM)
UK 100

Latest directors dealings